European Medicines Agency Grants NeuroSense SME Status, Offers Regulatory Guidance And Engagement In Dialogue With EMA
SME status offers regulatory guidance and engagement in dialogue with EMANeuroSense to open an EU office in Ulm, GermanyCompany plans to enroll patients at multiple sites across Europe in its planned Phase 3 pivotal ALS